Northwestern Mutual Wealth Management
VVOS icon

Northwestern Mutual Wealth Management’s Vivos Therapeutics VVOS Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio VVOS Stock Details VVOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3
Closed -$4 – 4482
2026
Q1 		$4 Buy
+3
New +$5 ﹤0.01% 4095

Other funds holding VVOS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
CWM
Centurion Wealth Management Mclean, Virginia $418M AUM 23.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

Northwestern Mutual Wealth Management's VVOS Position: Q2 2026 in Review

Northwestern Mutual Wealth Management sold out of Vivos Therapeutics (VVOS) in Q2 2026, closing a stake of 3 shares — an estimated $4 sold.

Northwestern Mutual Wealth Management first reported a position in VVOS in Q1 2026 and held it in 1 quarter. The position peaked at $4 in Q1 2026. 23 funds tracked by Wall St. Rank hold VVOS as of Q2 2026.

  • Northwestern Mutual Wealth Management reported no remaining Vivos Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 3 Vivos Therapeutics shares in Q2 2026, an estimated $4.
  • Northwestern Mutual Wealth Management first reported a position in Vivos Therapeutics in Q1 2026 and held it in 1 quarter.
  • Northwestern Mutual Wealth Management's Vivos Therapeutics position peaked at $4 in Q1 2026.
  • 23 funds tracked by Wall St. Rank held Vivos Therapeutics as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.